ANTIBODY AGAINST CYTOTOXIC LYMPHOCYTE MATURATION FACTOR

PROBLEM TO BE SOLVED: To provide an antibody against a novel cytokine protein called a cytotoxic lymphocyte maturation factor(CLMF) produced and synthesized by a human B-lymphoblast cell system. SOLUTION: This antibody is composed of a particular amino acid sequence (refer to the specification), has...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GATELY MAURICE KENT, PODLASKI FRANK JOHN, GUBLER ULRICH ANDREAS, CHIZZONITE RICHARD ANTHONY, HULMES JEFFREY DAVID, STERN ALVIN SETH, PAN YUING EUGENE
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide an antibody against a novel cytokine protein called a cytotoxic lymphocyte maturation factor(CLMF) produced and synthesized by a human B-lymphoblast cell system. SOLUTION: This antibody is composed of a particular amino acid sequence (refer to the specification), has at least 5.2×107 unit/mg of specific activity, and is an essencially pure polyclonal or monoclonal antibody to the cytotoxic lymphocyte maturation factor(CLMF) protein active by T-cell growth factor assay.